There’s a man in my mum’s sewing box. Staggeringly handsome and, until recently, rather mysterious. I hadn’t expected to be writing about a mystery again quite so soon after learning of the woman who may have been the face of Resusci Anne, but today I’m back with new Cochrane evidence which takes some of the mystery out of medicines for migraine, plus a look at migraine art and the man behind it. The man whose face has nestled among the cotton reels for the past sixty years.

Migraine is a common, complex and potentially disabling condition. Now we have new evidence from six Cochrane reviewsCochrane Reviews are systematic reviews. In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. on different drugs used for migraine, two on treating acuteA health condition (or episodes of a health condition) that comes on quickly and is short-lived. migraine and four on preventing episodic migraine in adults. Firstly treament, and two classes of drugs used to treat it, non-steroidal anti-inflammatory drugs (NSAIDs) and triptans.

Two new reviews have looked at the evidence for naproxen, a NSAID, on its own or combined with an anti-sickness drug and combined with sumatriptan, a triptan drug. The first found no randomizedRandomization is the process of randomly dividing into groups the people taking part in a trial. One group (the intervention group) will be given the intervention being tested (for example a drug, surgery, or exercise) and compared with a group which does not receive the intervention (the control group).   controlled trialsA trial in which a group (the ‘intervention group’) is given a intervention being tested (for example a drug, surgery, or exercise) is compared with a group which does not receive the intervention (the ‘control group’). (RCTs) of naproxen with an anti-sickness drug, but six good quality RCTs with around 2,700 people provides a comparison between naproxen, 500mg or 825mg doses, and placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine. (a dummy pill). Naproxen was only slightly better than placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine. at relieving migraine headache and it doesn’t look very useful. Two people in ten taking naproxen went from having moderate or severe pain to being pain free after two hours and one in ten taking placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine.. Almost five out of ten people had some headache relief with naproxen and three in ten with placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine..

Twelve good RCTs with around 9,300 people provided evidence about sumatriptan plus naproxen, which was much better than taking naproxen alone, though it’s not clear whether it’s better than sumatriptan on its own. About half those taking sumatriptan (50mg or 85mg) plus naproxen (500mg) were pain free after two hours compared with two in ten people taking placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine., when the pain was mild at the start. With more severe starting pain, six in ten taking the combination had only mild pain or none after two hours compared with three in ten taking placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine.. Results were similar whether a 50mg or 85mg dose of sumatriptan was taken. Treating early while the pain was still mild was more effective than delaying. There were more adverse effects with sumatriptan plus naproxen than with placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine. or naproxen alone but they were mild and mostly didn’t stop people taking it. Where they could be directly compared, the two drugs together were better than either alone, and side effects were more common with naproxen than sumatriptan.

So what works in preventing episodic migraine in adults, classed as migraines occurring on fewer than fifteen days per month? Anti-epileptic drugs are often used for this, including valproate (valproic acid or sodium valproate or both), gabapentin and the related drugs pregabalin and gabapentin enacarbil, topiramate, and four reviews published in June have looked at these.

There were some problems with the design and reporting of the ten trialsClinical trials are research studies involving people who use healthcare services. They often compare a new or different treatment with the best treatment currently available. This is to test whether the new or different treatment is safe, effective and any better than what is currently used. No matter how promising a new treatment may appear during tests in a laboratory, it must go through clinical trials before its benefits and risks can really be known. included in the review of valproate but the reviewers conclude that valproate is effective for migraine prevention and well tolerated, though it should be noted that it has been associated with birth defects so may not be safe for women who are pregnant or likely to conceive.

The review on topiramate found good evidence to support its routine use in preventing migraine, with adults taking topiramate having fewer headaches (1.2 fewer per month compared with placeboAn intervention that appears to be the same as that which is being assessed but does not have the active component. For example, a placebo could be a tablet made of sugar, compared with a tablet containing a medicine.) and tolerating it reasonably well, with side effects fairly common but mild. Again caution is urged for women of childbearing age – it has been associated with birth defects and may make low-dose hormonal contraception less effective. As one would expect, it had a positive effect on quality of life too. There was some evidence on comparative doses which suggests that 200mg is no more effective than 100mg. The reviewers highlight a need for future research to compare topiramate with other drugs and with other, non-drug options. Those included in this review were not able to provide clear answers, though it was interesting to see that the trialClinical trials are research studies involving people who use healthcare services. They often compare a new or different treatment with the best treatment currently available. This is to test whether the new or different treatment is safe, effective and any better than what is currently used. No matter how promising a new treatment may appear during tests in a laboratory, it must go through clinical trials before its benefits and risks can really be known. comparing relaxation with topiramate found that relaxation was more effective in improving migraine-related quality of life.

By contrast, the review on gabapentin found that neither gabapentin nor gabapentin enacarbil were helpful for preventing episodic migraine and side effects (especially dizziness and sleepiness) were common. The review included three unpublished and previously confidential drug company reports, six trialsClinical trials are research studies involving people who use healthcare services. They often compare a new or different treatment with the best treatment currently available. This is to test whether the new or different treatment is safe, effective and any better than what is currently used. No matter how promising a new treatment may appear during tests in a laboratory, it must go through clinical trials before its benefits and risks can really be known. in all. There was no published trialClinical trials are research studies involving people who use healthcare services. They often compare a new or different treatment with the best treatment currently available. This is to test whether the new or different treatment is safe, effective and any better than what is currently used. No matter how promising a new treatment may appear during tests in a laboratory, it must go through clinical trials before its benefits and risks can really be known. evidence on pregabalin. Another review looked for evidence on the effectivenessThe ability of an intervention (for example a drug, surgery, or exercise) to produce a desired effect, such as reduce symptoms. of anti-epileptic drugs other than gabapentin, pregabalin, topiramate, and valproate for episodic migraine in adults but the limitations of the evidence from ten studies of nine drugs mean that no conclusions can be drawn with any confidence.

So who was the man in the drawer? In the course of one month in 1951, my mother met the three most significant men in her life: her two husbands, whom she married 22 years apart, and the man in the photo, Derek Robinson.

A chance encounter at a youth hostel was followed by two years of happy times before they parted and we had no idea what Derek had done with his life until earlier this year, when I discovered his work in migraine art, a concept he created back in 1973. Whilst working for the pharmaceutical company Boehringer Ingelheim and searching for images to promote a new drug for preventing migraine, he was introduced to a woman who made paintings and sketches to help her doctor understand her migraine symptoms and came up with the idea of asking others to illustrate their experiences of migraine through art. In the 1980s he organized four Migraine Art competitions, sponsored by the Migraine Action Association (then the British Migraine AssociationA relationship between two characteristics, such that as one changes, the other changes in a predictable way. For example, statistics demonstrate that there is an association between smoking and lung cancer. In a positive association, one quantity increases as the other one increases (as with smoking and lung cancer). In a negative association, an increase in one quantity corresponds to a decrease in the other. Association does not necessarily mean that one thing causes the other.), and the response was overwhelming, with over 900 pictures being submitted. Derek managed the collection as its curator until his death in 2001. Migraine Art spawned Headache Art and has spun out across the globe, with competitions and exhibitions continuing to explain and inspire.

Images are from the Migraine Art collection, Migraine Action

Links:

Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic ReviewsIn systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2013, Issue 10. Art. No.: CD009455. DOI: 10.1002/14651858.CD009455.pub2.

• Cochrane summary http://summaries.cochrane.org/CD009455/naproxen-for-acute-migraine-in-adults Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults.

Cochrane Database of Systematic ReviewsIn systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2013, Issue 10. Art. No.: CD008541. DOI: 10.1002/14651858.CD008541.pub2.

• Cochrane summary http://summaries.cochrane.org/CD008541/sumatriptan-plus-naproxen-for-acute-migraine-attacks-in-adults

Linde M, Mulleners WM, Chronicle EP, McCrory DC. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic ReviewsIn systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2013, Issue 6. Art. No.: CD010611. DOI: 10.1002/14651858.CD010611

• Cochrane summary http://summaries.cochrane.org/CD010611/valproate-for-preventing-migraine-attacks-in-adults

Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic ReviewsIn systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2013, Issue 6. Art. No.: CD010610. DOI: 10.1002/14651858.CD010610.

• Cochrane summary http://summaries.cochrane.org/CD010610/topiramate-for-preventing-migraine-attacks-in-adults

Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic ReviewsIn systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2013, Issue 6. Art. No.: CD010609. DOI: 10.1002/14651858.CD010609.

• Cochrane summary http://summaries.cochrane.org/CD010609/gabapentin-or-pregabalin-for-preventing-migraine-attacks-in-adults

Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic ReviewsIn systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. 2013, Issue 6. Art. No.: CD010608. DOI: 10.1002/14651858.CD010608.

• Cochrane summary http://summaries.cochrane.org/CD010608/antiepileptics-other-than-gabapentin-pregabalin-topiramate-and-valproate-for-preventing-migraine-attacks-in-adults

Klaus Podoll The Migraine Art Competitions. Migraine Aura Foundation. Available online http://www.migraine-aura.com/content/e24966/e25413/e25619/index_en.html